Genomma Lab Internacional, S.A.B. de C.V. GEKA.F Stock
Genomma Lab Internacional, S.A.B. de C.V. Price Chart
Genomma Lab Internacional, S.A.B. de C.V. GEKA.F Financial and Trading Overview
Contents
- Genomma Lab Internacional, S.A.B. de C.V. Price Chart
- Genomma Lab Internacional, S.A.B. de C.V. GEKA.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Genomma Lab Internacional, S.A.B. de C.V.
- Q&A For Genomma Lab Internacional, S.A.B. de C.V. Stock
| Genomma Lab Internacional, S.A.B. de C.V. stock price | 0.86 EUR |
| Previous Close | 0.75 EUR |
| Open | 0.74 EUR |
| Bid | 0.74 EUR x 480000 |
| Ask | 0.78 EUR x 480000 |
| Day's Range | 0.74 - 0.74 EUR |
| 52 Week Range | 0.63 - 0.99 EUR |
| Volume | 2.35K EUR |
| Avg. Volume | 151 EUR |
| Market Cap | 718.37M EUR |
| Beta (5Y Monthly) | 0.561301 |
| PE Ratio (TTM) | 10.571428 |
| EPS (TTM) | 0.09 EUR |
| Forward Dividend & Yield | 0.05 (6.32%) |
| Ex-Dividend Date | June 5, 2023 |
| 1y Target Est | 23.53 EUR |
GEKA.F Valuation Measures
| Enterprise Value | 5.63B EUR |
| Trailing P/E | 10.571428 |
| Forward P/E | 0.38743457 |
| PEG Ratio (5 yr expected) | 0.68 |
| Price/Sales (ttm) | 0.0422022 |
| Price/Book (mrq) | 0.07239288 |
| Enterprise Value/Revenue | 0.331 |
| Enterprise Value/EBITDA | 1.593 |
Trading Information
Genomma Lab Internacional, S.A.B. de C.V. Stock Price History
| Beta (5Y Monthly) | 0.561301 |
| 52-Week Change | -17.032% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.99 EUR |
| 52 Week Low | 0.63 EUR |
| 50-Day Moving Average | 0.76 EUR |
| 200-Day Moving Average | 0.78 EUR |
GEKA.F Share Statistics
| Avg. Volume (3 month) | 151 EUR |
| Avg. Daily Volume (10-Days) | 235 EUR |
| Shares Outstanding | 964.51M |
| Float | 994.56M |
| Short Ratio | N/A |
| % Held by Insiders | 29.19% |
| % Held by Institutions | 29.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.578 |
| Trailing Annual Dividend Yield | 77.06% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.5326 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 8.31% |
| Operating Margin (ttm) | 19.33% |
| Gross Margin | 60.19% |
| EBITDA Margin | 20.74% |
Management Effectiveness
| Return on Assets (ttm) | 9.34% |
| Return on Equity (ttm) | 13.63% |
Income Statement
| Revenue (ttm) | 17.02B EUR |
| Revenue Per Share (ttm) | 16.95 EUR |
| Quarterly Revenue Growth (yoy) | 4.10% |
| Gross Profit (ttm) | 10.2B EUR |
| EBITDA | 3.53B EUR |
| Net Income Avi to Common (ttm) | 1.42B EUR |
| Diluted EPS (ttm) | 0.07 |
| Quarterly Earnings Growth (yoy) | 5.50% |
Balance Sheet
| Total Cash (mrq) | 1.25B EUR |
| Total Cash Per Share (mrq) | 1.26 EUR |
| Total Debt (mrq) | 6.12B EUR |
| Total Debt/Equity (mrq) | 59.01 EUR |
| Current Ratio (mrq) | 1.21 |
| Book Value Per Share (mrq) | 10.222 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.32B EUR |
| Levered Free Cash Flow (ttm) | 1.49B EUR |
Profile of Genomma Lab Internacional, S.A.B. de C.V.
| Country | Germany |
| State | DF |
| City | Mexico City |
| Address | Avenida Antonio Dovalí Jaime, number 70 |
| ZIP | 01210 |
| Phone | 52 55 5081 0000 |
| Website | https://www.genommalab.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of hydration, pains, fur, flu, hair, hemorrhoids, intimate health, infants, migraine, feet, baldness, imperfections, dandruff, cough, colitis, derma, back, performance, joints, onychomycosis, diabetes skin, warts, shave, diarrhea, pain, dream, and sexual health. The company offers its products under the Asepxia, Cicatricure, Suerox, Tio Nacho, Tafirol, Novamil, Groomen, Goicoechea, XL-3, Alliviax, Nizkon, QG-5, Lomecan, Unesia, Sistema GB, Teatrical, DiabeTX, Vanart, and various other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Q&A For Genomma Lab Internacional, S.A.B. de C.V. Stock
What is a current GEKA.F stock price?
Genomma Lab Internacional, S.A.B. de C.V. GEKA.F stock price today per share is 0.86 EUR.
How to purchase Genomma Lab Internacional, S.A.B. de C.V. stock?
You can buy GEKA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genomma Lab Internacional, S.A.B. de C.V.?
The stock symbol or ticker of Genomma Lab Internacional, S.A.B. de C.V. is GEKA.F.
Which industry does the Genomma Lab Internacional, S.A.B. de C.V. company belong to?
The Genomma Lab Internacional, S.A.B. de C.V. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Genomma Lab Internacional, S.A.B. de C.V. have in circulation?
The max supply of Genomma Lab Internacional, S.A.B. de C.V. shares is 966.94M.
What is Genomma Lab Internacional, S.A.B. de C.V. Price to Earnings Ratio (PE Ratio)?
Genomma Lab Internacional, S.A.B. de C.V. PE Ratio is 9.50000000 now.
What was Genomma Lab Internacional, S.A.B. de C.V. earnings per share over the trailing 12 months (TTM)?
Genomma Lab Internacional, S.A.B. de C.V. EPS is 0.09 EUR over the trailing 12 months.
Which sector does the Genomma Lab Internacional, S.A.B. de C.V. company belong to?
The Genomma Lab Internacional, S.A.B. de C.V. sector is Healthcare.